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Received March 8, 2011; accepted January 3, 2012AbstractPrimary infiltrating ductal carcinoma of the axillary breast is rare and has a high frequency of lymph node (LN) involvement.We report a woman
with primary infiltrating ductal carcinoma arising from the right axillary breast with metastasis to the contralateral chest wall. Excisional biopsy of
the left chest wall nodule and the right axillary mass was carried out and both showed invasive ductal carcinomas histologically. The lesion of the
right axillary mass arose from the breast tissue, rather than the LN. Further surgery proved the right axillary LN metastasis. After further review, a
primary infiltrating ductal carcinoma of the right axillary breast with metastasis to axillary LNs and contralateral chest wall was diagnosed. The
patient also received chemotherapy and radiation and there was no evidence of tumor recurrence after treatment. The present report demonstrated a
rare case with uncommon manifestation. Lesions of uncertain origin around the periphery of the breast should be suspected for breast carcinoma.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Ectopic breast tissue is reported in 2e6% of the general
population, with most cases being located in the axillary
region.1e4 The same pathology that can affect normally
positioned breasts, including carcinoma, can occur in ectopic
breast tissue.5 Primary carcinoma of ectopic breast tissue has
been reported only in a small number of cases. High frequency
of axillary node involvements was noted for cancer arising
from the axillary breast.2* Corresponding author. Dr. Li-Min Chung, Department of Medical
Oncology, Zuoying Armed Forces General Hospital, 553, Junxiao Rd, Zuoying
District, Kaohsiung 813, Taiwan, ROC.
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A 50-year-old female patient had a history of left breast
phyllodes tumor after subcutaneous mastectomy in April
2007. The pathologic findings showed an overgrowing hy-
percellular mesenchymal component (Fig. 1A), and mitotic
figure revealed 4/10 high power field (HPF) (Fig. 1B), which
were consistent with phyllodes tumor. She had chief com-
plaints of several small nodules over the surgical scar area
since July 2009. Physical examination found several small
(<1 cm) nodules over the left chest wall just around the prior
surgical scar. Breast echogram showed post-mastectomy with
some small nodules in the superficial fatty layer and lymph-
adenopathy was suspected. Confluent soft tissue nodes in the
right axillary region were also detected. A mammogramhinese Medical Association. All rights reserved.
Fig. 1. Histological staining of the left breast tumor showed: (A) the epithelial
component arranged in clefts surrounded by an overgrowing hypercellular
mesenchymal component; (B) mitotic figure revealed 4/10 HPF (arrow). HPF.
Fig. 2. Specimens from (A) the right axillary mass and (B) the left chest wall
showed invasive ductal carcinoma. Ectopic breast tissue (arrow) was found
adjacent to the tumor.
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region may be due to lymph node (LN) involvement, and there
was no evidence of mass shadow or malignant calcification in
breast parenchyma.
She received excisional biopsy, and pathology revealed a
2.3-cm invasive ductal carcinoma arising from the right axil-
lary breast (Fig. 2A), and the left chest wall nodules also
showed this pattern (Fig. 2B). The histology from both speci-
mens showed: (1) estrogen receptor (ER), moderately positive
intensity in 90% of tumor cells; (2) progesterone receptor (PR),
moderately positive intensity in 90% of tumor cells; (3) HER2/
neu, weakly positive intensity in 60% of tumor cells (þ/þþþ);
(4) immunohistochemical stain, GCDFP-15(þ); and (5) his-
tological grade II. A postoperative positron emission tomog-
raphyecomputed tomography (PETeCT) scan displayed
residual tumor or post-biopsy inflammatory change over the
left chest wall, and mildly elevated fluorodeoxyglucose (FDG)
uptake in the right axillary and mediastinal regions (Fig. 3).
The patient received further surgery to her right axillary
breast and LNs, and the pathology showed post-excision
changes without residual tumor over the right axillary breast,
but metastatic invasive ductal carcinoma was noted in the right
axillary LNs. Five out of six were positive for level I, and three
out of three for level II.The final diagnosis was invasive ductal carcinoma of the
right axillary breast with regional axillary LN metastasis. The
left chest wall nodules were probably the metastatic lesions
from the right axillary breast cancer; however, it could be
synchronous cancer, and this remains undetermined.
The patient received six cycles of chemotherapy with
paclitaxel 240mg and cisplatin 80mg. The subsequent chest CT
scan found the prior enlarged mediastinal LN disappeared, but
the left chest wall nodules did not regress. The patient received
local radiotherapy (RT) after chemotherapy. The RT fields
covered the right axillary area and the ipsilateral supraclavicular
area for 50.4 Gy, followed by the electron beam boost to the
right axillary surgical scar for an additional 10.8 Gy. The left
chest wall scattered nodules were irradiated by the electron
beam for 50.4 Gy. The nodules over the left chest wall dis-
appeared after radiation. The treatment course was smooth
without any unexpected interruption. Currently, the patient has
no evidence of disease 18 months after the diagnosis.
3. Discussion
Wepresented a rare case of primary axillary breast cancerwith
an unusual presentation. The patient’s past history of phyllodes
Fig. 3. PETeCT displayed mildly elevated FDG uptake over the right axillary (A) and mediastinal (B) regions. FDG ¼ fluorodeoxyglucose; PETeCT ¼ positron
emission tomographyecomputed tomography.
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beginning. Phyllodes tumor is a fibro-epithelial tumor composed
of an epithelial and a cellular stromal component. They account
for less than 1% of all breast neoplasms. They may be considered
benign, borderline, or malignant depending on histologic fea-
tures.6,7 Malignant phyllodes tumor should be classified as
sarcoma, and its origin is different from the infiltrating ductal
carcinoma. After reviewing the patient’s previous slides, we
found that the histopathologic findings of her left breast tumor
were consistent with phyllodes tumor, and were different from
the current malignancy, which showed infiltrating ductal
carcinoma.
Primary breast cancer in aberrant axillary breast tissue is
rare. Evans et al carried out a review of axillary breast car-
cinoma in 1995. They reported 90 cases of carcinoma of
ectopic breast tissue, 64 of which occurred in the axilla. The 4-
year survival rate was only 9.4%. They also concluded that
there is no survival advantage for radical mastectomy over that
of local excision combined with axillary dissection or radia-
tion and the addition of radiation to mastectomy provided noadditional benefit.3 However, this review was carried out 16
years ago and the conclusion could be revised when we apply
the modern treatment concepts.
In general, the prognosis for cancer arising from the axil-
lary breast is worse than from the main breast. Due to its
unusual location and normally absent overlying accessory
areola or nipple, there is a general lack of awareness among
physicians and patients, and clinical diagnosis is frequently
delayed. In addition, the location of the axillary breast causes a
high frequency of LN involvement.1,8,9 To avoid delays in
diagnosis, it is suggested that subcutaneous lesions of uncer-
tain origin around the periphery of the breast should be sus-
pected to be breast cancer.10
The optimal treatment consensus is not established yet due to
its rarity. Based on its clinical manifestation and the limited
available data,2,11e14 we suggested the general treatment prin-
ciple should follow the current recommendations for treatment
of anatomic breast cancer with emphasis on the coverage of
regional LNs and to spare more breast tissue if possible. Sur-
gical intervention to the axillary breast and axillary LNs
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treatment plan of choice for most cases. An ipsilateral pro-
phylactic mastectomy performed in the presence of a well-
documented ectopic tumor is usually not recommended
because it has not been shown to offer a significant survival
advantage over resection of the ectopic breastmass and involved
LNs.13,15 The role of adjuvant therapy is not well defined due to
the paucity of information in the literature, but we suggest
giving more aggressive adjuvant therapy based on the tendency
of delayed diagnosis and high incidence of LN metastases.
Chemotherapy should be considered for most cases. Target
therapy and/or hormone therapy could be reserved for patients
with positive receptor(s). Radiation should be given to all cases
of breast conservative surgery. The irradiated site should cover
the ectopic axillary tumors and LNs for all of these patients. The
role of RT to the ipsilateral normal breast is still not clear.
Marshall et al reported that none of the ectopic breast cancers
spread to the ipsilateral breast; however, there were three later
recurrences of breast cancer in the ipsilateral breast.12 Our pa-
tient’s PET scan examination showed the possible lesions in the
right axillary area, left chest wall, and mediastinum. The
mediastinal lesion regressed after chemotherapy, but the nod-
ules over the left chest wall persisted. Our policy for RTwas to
cover the right axillary area, the right supraclavicular area, and
the left chest wall. Her right breast and mediastinum will be
closely followed up.
The presented case had the same pathological feature of left
chest wall nodules. We believe it is most likely the metastatic
lesion from the right axillary breast cancer. However, the
possibility of synchronous cancer cannot be totally ruled out.
Metastatic spread to the ipsilateral breast has not been reported
previously.16 Our case might be the first case reported with
metastasis to the contralateral chest wall. However, the inci-
dence of concurrent cancers of an ectopic breast and an ipsi-
lateral anatomically correct breast is highly unusual.12 To the
best of our knowledge, a synchronous cancer on the contra-
lateral chest wall has not been reported to date, therefore our
case might be the first.
In conclusion, axillary breast cancer is relatively rare and
awareness of the potential diagnosis is warranted to avoiddelayed diagnosis. The optimal treatment method is still un-
determined. Currently, the recommendations for treatment are
based on the guidelines of tumor staging of normal anatomic
breast cancer.References
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